Nichepharm Lifesciences (P) Ltd.

Nichepharm Lifesciences (P) Ltd. company information, Employees & Contact Information

Nichepharm Lifesciences Pvt. Limited is a pharmaceutical company envisaged to meet the growing demands of sterile injectable and biologics in the highly regulated markets of US and Europe and provide access to affordable medicines for the Indian subcontinent and ROW markets. As the name suggests, the company is focused to manufacture the niche and difficult to make pharmaceutical dosages leveraging the vast expertise of the promoters who have experience of over 2 decades in successfully managing and running sterile facilities. The company is being set up as a joint venture between the Sobti Family and Recipharm AB (among the top 5 CDMOs worldwide). The partnership brings on the table brand and recognitions, market intelligence and access to world class technology and penetration to markets with huge entry barriers. The company is headquartered at Gurgaon, Haryana and has a state-of-the-art manufacturing facility located at Selaqui Dehradun commissioned in 2021. The facility is compliant with all international regulatory authorities with a capability to manufacture a wide range of small volume parenteral and offers largest capacities in injectable space in India under one roof. Adhering to the objective “Aiming for the next level”, Nichepharm continues to strive for excellency in all their products and service offerings customized towards meeting highest level of customer satisfaction.

Company Details

Employees
95
Founded
-
Address
1, Golf Course Road, Sector - 56, 401,baani,india
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Gurgaon, Haryana
Looking for a particular Nichepharm Lifesciences (P) Ltd. employee's phone or email?

Nichepharm Lifesciences (P) Ltd. Questions

News

Avendus advises Nichepharm Lifesciences and the Sobti Family, on its complete acquisition of 24% shares from Swedish-based Recipharm AB - Avendus

Avendus advises Nichepharm Lifesciences and the Sobti Family, on its complete acquisition of 24% shares from Swedish-based Recipharm AB Avendus

Nichepharm acquires 24% remaining shares from Recipharm AB to restore 100% ownership - financialexpress.com

Nichepharm acquires 24% remaining shares from Recipharm AB to restore 100% ownership financialexpress.com

Recipharm Invests in Nichepharm Lifesciences - Contract Pharma

Recipharm Invests in Nichepharm Lifesciences Contract Pharma

Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy - Fierce Pharma

Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy Fierce Pharma

Avendus advises Nichepharm Lifesciences and the Sobti Family, on its complete acquisition of 24% shares from Swedish-based Recipharm AB - Avendus

Avendus advises Nichepharm Lifesciences and the Sobti Family, on its complete acquisition of 24% shares from Swedish-based Recipharm AB Avendus

CDMO Recipharm continues its rapid expansion with a second fill-finish facility, this time in India - Fierce Pharma

CDMO Recipharm continues its rapid expansion with a second fill-finish facility, this time in India Fierce Pharma

Top Nichepharm Lifesciences (P) Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant